COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    NCT04326920
Previous Study | Return to List | Next Study

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) (SARPAC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04326920
Recruitment Status : Recruiting
First Posted : March 30, 2020
Last Update Posted : April 24, 2020
Flanders Institute of Biotechnology
Information provided by (Responsible Party):
Bart N. Lambrecht, University Hospital, Ghent